•
GU
GUTS
Fractyl Health, Inc. Common Stock
polygonSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
283.74M
Volume
2.09M
52W High
$3.03
52W Low
$0.83
Open
$1.87
Prev Close
$1.85
Day Range
1.87 - 2.17
About Fractyl Health, Inc. Common Stock
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Latest News
Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones
GlobeNewswire Inc.•Dec 15
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
GlobeNewswire Inc.•Dec 2
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.•Dec 1
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
GlobeNewswire Inc.•Nov 5
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation
GlobeNewswire Inc.•Sep 26
Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth
GlobeNewswire Inc.•Sep 3
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
GlobeNewswire Inc.•Jun 13
Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
GlobeNewswire Inc.•May 19